Curis, Inc.

Curis, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Curis, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Curis, Inc..
Log in to see more information.
Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of...
CRIS Fundamental Data by TradingView

News

Curis to Present at Upcoming Healthcare Conferences in September
Curis to Present at Upcoming Healthcare Conferences in September

PR Newswire Curis to Present at Upcoming Healthcare Conferences in September Curis to Present at Upcoming Healthcare Conferences in September PR Newswire LEXINGTON, Mass., Sept. 4, 2024 LEXINGTON, Mass., Sept...\n more…

Curis, Inc. (NASDAQ:CRIS) Shares Purchased by Vanguard Group Inc.
Curis, Inc. (NASDAQ:CRIS) Shares Purchased by Vanguard Group Inc.

Ticker Report Vanguard Group Inc. boosted its stake in Curis, Inc. (NASDAQ:CRIS - Free Report) by 4.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange...\n more…

Head-To-Head Comparison: Curis (NASDAQ:CRIS) vs. DBV Technologies (NASDAQ:DBVT)
Head-To-Head Comparison: Curis (NASDAQ:CRIS) vs. DBV Technologies (NASDAQ:DBVT)

Zolmax Curis (NASDAQ:CRIS - Get Free Report) and DBV Technologies (NASDAQ:DBVT - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses...\n more…

Contrasting Curis (NASDAQ:CRIS) and DBV Technologies (NASDAQ:DBVT)
Contrasting Curis (NASDAQ:CRIS) and DBV Technologies (NASDAQ:DBVT)

Ticker Report DBV Technologies (NASDAQ:DBVT - Get Free Report) and Curis (NASDAQ:CRIS - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies...\n more…

Growth Investors: Industry Analysts Just Upgraded Their Curis, Inc. (NASDAQ:CRIS) Revenue Forecasts By 15%
Growth Investors: Industry Analysts Just Upgraded Their Curis, Inc. (NASDAQ:CRIS) Revenue Forecasts By 15%

Simply Wall St Curis, Inc. ( NASDAQ:CRIS ) shareholders will have a reason to smile today, with the analysts making substantial...\n more…

Improved Revenues Required Before Curis, Inc. (NASDAQ:CRIS) Shares Find Their Feet
Improved Revenues Required Before Curis, Inc. (NASDAQ:CRIS) Shares Find Their Feet

Simply Wall St With a price-to-sales (or "P/S") ratio of 2.9x Curis, Inc. ( NASDAQ:CRIS ) may be sending very bullish signals at the...\n more…